Hepatocellular carcinoma is the fourth leading cause of cancer-related death worldwide.
Depending on the extent of disease and competing comorbidities for mortality, multiple liver …

Stereotactic Body Radiation Therapy (SBRT) is an emerging effective treatment for
hepatocellular carcinoma (HCC) associated with acceptable rates of toxicity in appropriately …

Background Accurate prediction of radiation toxicity of healthy organs‐at‐risks (OAR s)
critically determines the radiation therapy (RT) success. The existing dose–volume …

Purpose Ablative radiation therapy is increasingly being used for hepatocellular carcinoma
(HCC) resulting in excellent local control rates; however, patients without evidence of …

Objectives To evaluate the feasibility and efficacy of stereotactic body radiation therapy
(SBRT) in the treatment of hepatocellular carcinoma (HCC) unsuitable for standard loco …

Methods A phase II, single-arm clinical trial on SBRT for small HCCs was conducted at an
academic tertiary care center. The planned SBRT dose was 45 Gy with a fraction size of 15 …

Purpose To describe efficacy and safety of stereotactic body radiation therapy (SBRT) for the
treatment of inoperable hepatocellular carcinoma. Methods The records of 77 consecutive …

Purpose To perform a systematic review and meta-analysis to compare the clinical
outcomes and toxicity of hepatocellular carcinoma (HCC) patients treated with charged …

Background: Stereotactic body radiation therapy (SBRT) is an advanced technique of
external beam radiation therapy that delivers large ablative doses of radiation. In the past …

Despite the historically limited role of radiotherapy in the management of primary hepatic
malignancies, modern advances in treatment design and delivery have renewed …